Vonoprazan Fumarate(CAS?1260141-27-2) is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB), with potential antacid activity.
The global market for Vonoprazan Fumarate API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Vonoprazan Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Vonoprazan Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Vonoprazan Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Vonoprazan Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Vonoprazan Fumarate API players cover Ami Lifesciences Private Limited, Dr. Reddy's Laboratories, Hetero Drugs, Metrochem API Private Limited and Nippon Zhenlei Chemical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Vonoprazan Fumarate API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Vonoprazan Fumarate API market, with both quantitative and qualitative data, to help readers understand how the Vonoprazan Fumarate API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Vonoprazan Fumarate API market and forecasts the market size by Purity (Above 98 % and Above 99 %,), by Application (Tablets and Others.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
Above 98 %
Above 99 %
Segmentation by application
Tablets
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Ami Lifesciences Private Limited
Dr. Reddy's Laboratories
Hetero Drugs
Metrochem API Private Limited
Nippon Zhenlei Chemical
Virupaksha Organics
Zhejiang Hengkang Pharmaceutical
Maithri Drugs
Xian Wanlong Pharmaceutical
Morepen Laboratories
Chapter Introduction
Chapter 1: Scope of Vonoprazan Fumarate API, Research Methodology, etc.
Chapter 2: Executive Summary, global Vonoprazan Fumarate API market size (sales and revenue) and CAGR, Vonoprazan Fumarate API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Vonoprazan Fumarate API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Vonoprazan Fumarate API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Vonoprazan Fumarate API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Ami Lifesciences Private Limited, Dr. Reddy's Laboratories, Hetero Drugs, Metrochem API Private Limited, Nippon Zhenlei Chemical, Virupaksha Organics, Zhejiang Hengkang Pharmaceutical, Maithri Drugs and Xian Wanlong Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vonoprazan Fumarate API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vonoprazan Fumarate API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vonoprazan Fumarate API by Country/Region, 2017, 2022 & 2028
2.2 Vonoprazan Fumarate API Segment by Purity
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Vonoprazan Fumarate API Sales by Purity
2.3.1 Global Vonoprazan Fumarate API Sales Market Share by Purity (2017-2022)
2.3.2 Global Vonoprazan Fumarate API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Vonoprazan Fumarate API Sale Price by Purity (2017-2022)
2.4 Vonoprazan Fumarate API Segment by Application
2.4.1 Tablets
2.4.2 Others
2.5 Vonoprazan Fumarate API Sales by Application
2.5.1 Global Vonoprazan Fumarate API Sale Market Share by Application (2017-2022)
2.5.2 Global Vonoprazan Fumarate API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vonoprazan Fumarate API Sale Price by Application (2017-2022)
3 Global Vonoprazan Fumarate API by Company
3.1 Global Vonoprazan Fumarate API Breakdown Data by Company
3.1.1 Global Vonoprazan Fumarate API Annual Sales by Company (2020-2022)
3.1.2 Global Vonoprazan Fumarate API Sales Market Share by Company (2020-2022)
3.2 Global Vonoprazan Fumarate API Annual Revenue by Company (2020-2022)
3.2.1 Global Vonoprazan Fumarate API Revenue by Company (2020-2022)
3.2.2 Global Vonoprazan Fumarate API Revenue Market Share by Company (2020-2022)
3.3 Global Vonoprazan Fumarate API Sale Price by Company
3.4 Key Manufacturers Vonoprazan Fumarate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vonoprazan Fumarate API Product Location Distribution
3.4.2 Players Vonoprazan Fumarate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vonoprazan Fumarate API by Geographic Region
4.1 World Historic Vonoprazan Fumarate API Market Size by Geographic Region (2017-2022)
4.1.1 Global Vonoprazan Fumarate API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vonoprazan Fumarate API Annual Revenue by Geographic Region
4.2 World Historic Vonoprazan Fumarate API Market Size by Country/Region (2017-2022)
4.2.1 Global Vonoprazan Fumarate API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vonoprazan Fumarate API Annual Revenue by Country/Region
4.3 Americas Vonoprazan Fumarate API Sales Growth
4.4 APAC Vonoprazan Fumarate API Sales Growth
4.5 Europe Vonoprazan Fumarate API Sales Growth
4.6 Middle East & Africa Vonoprazan Fumarate API Sales Growth
5 Americas
5.1 Americas Vonoprazan Fumarate API Sales by Country
5.1.1 Americas Vonoprazan Fumarate API Sales by Country (2017-2022)
5.1.2 Americas Vonoprazan Fumarate API Revenue by Country (2017-2022)
5.2 Americas Vonoprazan Fumarate API Sales by Purity
5.3 Americas Vonoprazan Fumarate API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vonoprazan Fumarate API Sales by Region
6.1.1 APAC Vonoprazan Fumarate API Sales by Region (2017-2022)
6.1.2 APAC Vonoprazan Fumarate API Revenue by Region (2017-2022)
6.2 APAC Vonoprazan Fumarate API Sales by Purity
6.3 APAC Vonoprazan Fumarate API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vonoprazan Fumarate API by Country
7.1.1 Europe Vonoprazan Fumarate API Sales by Country (2017-2022)
7.1.2 Europe Vonoprazan Fumarate API Revenue by Country (2017-2022)
7.2 Europe Vonoprazan Fumarate API Sales by Purity
7.3 Europe Vonoprazan Fumarate API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vonoprazan Fumarate API by Country
8.1.1 Middle East & Africa Vonoprazan Fumarate API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vonoprazan Fumarate API Revenue by Country (2017-2022)
8.2 Middle East & Africa Vonoprazan Fumarate API Sales by Purity
8.3 Middle East & Africa Vonoprazan Fumarate API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vonoprazan Fumarate API
10.3 Manufacturing Process Analysis of Vonoprazan Fumarate API
10.4 Industry Chain Structure of Vonoprazan Fumarate API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vonoprazan Fumarate API Distributors
11.3 Vonoprazan Fumarate API Customer
12 World Forecast Review for Vonoprazan Fumarate API by Geographic Region
12.1 Global Vonoprazan Fumarate API Market Size Forecast by Region
12.1.1 Global Vonoprazan Fumarate API Forecast by Region (2023-2028)
12.1.2 Global Vonoprazan Fumarate API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vonoprazan Fumarate API Forecast by Purity
12.7 Global Vonoprazan Fumarate API Forecast by Application
13 Key Players Analysis
13.1 Ami Lifesciences Private Limited
13.1.1 Ami Lifesciences Private Limited Company Information
13.1.2 Ami Lifesciences Private Limited Vonoprazan Fumarate API Product Offered
13.1.3 Ami Lifesciences Private Limited Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ami Lifesciences Private Limited Main Business Overview
13.1.5 Ami Lifesciences Private Limited Latest Developments
13.2 Dr. Reddy's Laboratories
13.2.1 Dr. Reddy's Laboratories Company Information
13.2.2 Dr. Reddy's Laboratories Vonoprazan Fumarate API Product Offered
13.2.3 Dr. Reddy's Laboratories Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Dr. Reddy's Laboratories Main Business Overview
13.2.5 Dr. Reddy's Laboratories Latest Developments
13.3 Hetero Drugs
13.3.1 Hetero Drugs Company Information
13.3.2 Hetero Drugs Vonoprazan Fumarate API Product Offered
13.3.3 Hetero Drugs Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Hetero Drugs Main Business Overview
13.3.5 Hetero Drugs Latest Developments
13.4 Metrochem API Private Limited
13.4.1 Metrochem API Private Limited Company Information
13.4.2 Metrochem API Private Limited Vonoprazan Fumarate API Product Offered
13.4.3 Metrochem API Private Limited Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Metrochem API Private Limited Main Business Overview
13.4.5 Metrochem API Private Limited Latest Developments
13.5 Nippon Zhenlei Chemical
13.5.1 Nippon Zhenlei Chemical Company Information
13.5.2 Nippon Zhenlei Chemical Vonoprazan Fumarate API Product Offered
13.5.3 Nippon Zhenlei Chemical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Nippon Zhenlei Chemical Main Business Overview
13.5.5 Nippon Zhenlei Chemical Latest Developments
13.6 Virupaksha Organics
13.6.1 Virupaksha Organics Company Information
13.6.2 Virupaksha Organics Vonoprazan Fumarate API Product Offered
13.6.3 Virupaksha Organics Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Virupaksha Organics Main Business Overview
13.6.5 Virupaksha Organics Latest Developments
13.7 Zhejiang Hengkang Pharmaceutical
13.7.1 Zhejiang Hengkang Pharmaceutical Company Information
13.7.2 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Product Offered
13.7.3 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Zhejiang Hengkang Pharmaceutical Main Business Overview
13.7.5 Zhejiang Hengkang Pharmaceutical Latest Developments
13.8 Maithri Drugs
13.8.1 Maithri Drugs Company Information
13.8.2 Maithri Drugs Vonoprazan Fumarate API Product Offered
13.8.3 Maithri Drugs Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Maithri Drugs Main Business Overview
13.8.5 Maithri Drugs Latest Developments
13.9 Xian Wanlong Pharmaceutical
13.9.1 Xian Wanlong Pharmaceutical Company Information
13.9.2 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Product Offered
13.9.3 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Xian Wanlong Pharmaceutical Main Business Overview
13.9.5 Xian Wanlong Pharmaceutical Latest Developments
13.10 Morepen Laboratories
13.10.1 Morepen Laboratories Company Information
13.10.2 Morepen Laboratories Vonoprazan Fumarate API Product Offered
13.10.3 Morepen Laboratories Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Morepen Laboratories Main Business Overview
13.10.5 Morepen Laboratories Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Vonoprazan Fumarate API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vonoprazan Fumarate API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Vonoprazan Fumarate API Sales by Purity (2017-2022) & (Kg)
Table 6. Global Vonoprazan Fumarate API Sales Market Share by Purity (2017-2022)
Table 7. Global Vonoprazan Fumarate API Revenue by Purity (2017-2022) & ($ million)
Table 8. Global Vonoprazan Fumarate API Revenue Market Share by Purity (2017-2022)
Table 9. Global Vonoprazan Fumarate API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 10. Global Vonoprazan Fumarate API Sales by Application (2017-2022) & (Kg)
Table 11. Global Vonoprazan Fumarate API Sales Market Share by Application (2017-2022)
Table 12. Global Vonoprazan Fumarate API Revenue by Application (2017-2022)
Table 13. Global Vonoprazan Fumarate API Revenue Market Share by Application (2017-2022)
Table 14. Global Vonoprazan Fumarate API Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Vonoprazan Fumarate API Sales by Company (2020-2022) & (Kg)
Table 16. Global Vonoprazan Fumarate API Sales Market Share by Company (2020-2022)
Table 17. Global Vonoprazan Fumarate API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vonoprazan Fumarate API Revenue Market Share by Company (2020-2022)
Table 19. Global Vonoprazan Fumarate API Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Vonoprazan Fumarate API Producing Area Distribution and Sales Area
Table 21. Players Vonoprazan Fumarate API Products Offered
Table 22. Vonoprazan Fumarate API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vonoprazan Fumarate API Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Vonoprazan Fumarate API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vonoprazan Fumarate API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vonoprazan Fumarate API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vonoprazan Fumarate API Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Vonoprazan Fumarate API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vonoprazan Fumarate API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vonoprazan Fumarate API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vonoprazan Fumarate API Sales by Country (2017-2022) & (Kg)
Table 34. Americas Vonoprazan Fumarate API Sales Market Share by Country (2017-2022)
Table 35. Americas Vonoprazan Fumarate API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vonoprazan Fumarate API Revenue Market Share by Country (2017-2022)
Table 37. Americas Vonoprazan Fumarate API Sales by Type (2017-2022) & (Kg)
Table 38. Americas Vonoprazan Fumarate API Sales Market Share by Purity (2017-2022)
Table 39. Americas Vonoprazan Fumarate API Sales by Application (2017-2022) & (Kg)
Table 40. Americas Vonoprazan Fumarate API Sales Market Share by Application (2017-2022)
Table 41. APAC Vonoprazan Fumarate API Sales by Region (2017-2022) & (Kg)
Table 42. APAC Vonoprazan Fumarate API Sales Market Share by Region (2017-2022)
Table 43. APAC Vonoprazan Fumarate API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vonoprazan Fumarate API Revenue Market Share by Region (2017-2022)
Table 45. APAC Vonoprazan Fumarate API Sales by Purity (2017-2022) & (Kg)
Table 46. APAC Vonoprazan Fumarate API Sales Market Share by Purity (2017-2022)
Table 47. APAC Vonoprazan Fumarate API Sales by Application (2017-2022) & (Kg)
Table 48. APAC Vonoprazan Fumarate API Sales Market Share by Application (2017-2022)
Table 49. Europe Vonoprazan Fumarate API Sales by Country (2017-2022) & (Kg)
Table 50. Europe Vonoprazan Fumarate API Sales Market Share by Country (2017-2022)
Table 51. Europe Vonoprazan Fumarate API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vonoprazan Fumarate API Revenue Market Share by Country (2017-2022)
Table 53. Europe Vonoprazan Fumarate API Sales by Type (2017-2022) & (Kg)
Table 54. Europe Vonoprazan Fumarate API Sales Market Share by Purity (2017-2022)
Table 55. Europe Vonoprazan Fumarate API Sales by Application (2017-2022) & (Kg)
Table 56. Europe Vonoprazan Fumarate API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vonoprazan Fumarate API Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vonoprazan Fumarate API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vonoprazan Fumarate API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vonoprazan Fumarate API Sales by Purity (2017-2022) & (Kg)
Table 62. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Purity (2017-2022)
Table 63. Middle East & Africa Vonoprazan Fumarate API Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vonoprazan Fumarate API
Table 66. Key Market Challenges & Risks of Vonoprazan Fumarate API
Table 67. Key Industry Trends of Vonoprazan Fumarate API
Table 68. Vonoprazan Fumarate API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vonoprazan Fumarate API Distributors List
Table 71. Vonoprazan Fumarate API Customer List
Table 72. Global Vonoprazan Fumarate API Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Vonoprazan Fumarate API Sales Market Forecast by Region
Table 74. Global Vonoprazan Fumarate API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vonoprazan Fumarate API Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Vonoprazan Fumarate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vonoprazan Fumarate API Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Vonoprazan Fumarate API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vonoprazan Fumarate API Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Vonoprazan Fumarate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vonoprazan Fumarate API Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Vonoprazan Fumarate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vonoprazan Fumarate API Sales Forecast by Purity (2023-2028) & (Kg)
Table 85. Global Vonoprazan Fumarate API Sales Market Share Forecast by Purity (2023-2028)
Table 86. Global Vonoprazan Fumarate API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 87. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Purity (2023-2028)
Table 88. Global Vonoprazan Fumarate API Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Vonoprazan Fumarate API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vonoprazan Fumarate API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Ami Lifesciences Private Limited Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 93. Ami Lifesciences Private Limited Vonoprazan Fumarate API Product Offered
Table 94. Ami Lifesciences Private Limited Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. Ami Lifesciences Private Limited Main Business
Table 96. Ami Lifesciences Private Limited Latest Developments
Table 97. Dr. Reddy's Laboratories Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr. Reddy's Laboratories Vonoprazan Fumarate API Product Offered
Table 99. Dr. Reddy's Laboratories Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Dr. Reddy's Laboratories Main Business
Table 101. Dr. Reddy's Laboratories Latest Developments
Table 102. Hetero Drugs Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 103. Hetero Drugs Vonoprazan Fumarate API Product Offered
Table 104. Hetero Drugs Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Hetero Drugs Main Business
Table 106. Hetero Drugs Latest Developments
Table 107. Metrochem API Private Limited Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 108. Metrochem API Private Limited Vonoprazan Fumarate API Product Offered
Table 109. Metrochem API Private Limited Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Metrochem API Private Limited Main Business
Table 111. Metrochem API Private Limited Latest Developments
Table 112. Nippon Zhenlei Chemical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 113. Nippon Zhenlei Chemical Vonoprazan Fumarate API Product Offered
Table 114. Nippon Zhenlei Chemical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Nippon Zhenlei Chemical Main Business
Table 116. Nippon Zhenlei Chemical Latest Developments
Table 117. Virupaksha Organics Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 118. Virupaksha Organics Vonoprazan Fumarate API Product Offered
Table 119. Virupaksha Organics Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Virupaksha Organics Main Business
Table 121. Virupaksha Organics Latest Developments
Table 122. Zhejiang Hengkang Pharmaceutical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 123. Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Product Offered
Table 124. Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Zhejiang Hengkang Pharmaceutical Main Business
Table 126. Zhejiang Hengkang Pharmaceutical Latest Developments
Table 127. Maithri Drugs Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 128. Maithri Drugs Vonoprazan Fumarate API Product Offered
Table 129. Maithri Drugs Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Maithri Drugs Main Business
Table 131. Maithri Drugs Latest Developments
Table 132. Xian Wanlong Pharmaceutical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 133. Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Product Offered
Table 134. Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Xian Wanlong Pharmaceutical Main Business
Table 136. Xian Wanlong Pharmaceutical Latest Developments
Table 137. Morepen Laboratories Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 138. Morepen Laboratories Vonoprazan Fumarate API Product Offered
Table 139. Morepen Laboratories Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. Morepen Laboratories Main Business
Table 141. Morepen Laboratories Latest Developments
List of Figures
Figure 1. Picture of Vonoprazan Fumarate API
Figure 2. Vonoprazan Fumarate API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vonoprazan Fumarate API Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Vonoprazan Fumarate API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vonoprazan Fumarate API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Vonoprazan Fumarate API Sales Market Share by Purity in 2021
Figure 12. Global Vonoprazan Fumarate API Revenue Market Share by Purity (2017-2022)
Figure 13. Vonoprazan Fumarate API Consumed in Tablets
Figure 14. Global Vonoprazan Fumarate API Market: Tablets (2017-2022) & (Kg)
Figure 15. Vonoprazan Fumarate API Consumed in Others
Figure 16. Global Vonoprazan Fumarate API Market: Others (2017-2022) & (Kg)
Figure 17. Global Vonoprazan Fumarate API Sales Market Share by Application (2017-2022)
Figure 18. Global Vonoprazan Fumarate API Revenue Market Share by Application in 2021
Figure 19. Vonoprazan Fumarate API Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Vonoprazan Fumarate API Revenue Market Share by Company in 2021
Figure 21. Global Vonoprazan Fumarate API Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Vonoprazan Fumarate API Revenue Market Share by Geographic Region in 2021
Figure 23. Global Vonoprazan Fumarate API Sales Market Share by Region (2017-2022)
Figure 24. Global Vonoprazan Fumarate API Revenue Market Share by Country/Region in 2021
Figure 25. Americas Vonoprazan Fumarate API Sales 2017-2022 (Kg)
Figure 26. Americas Vonoprazan Fumarate API Revenue 2017-2022 ($ Millions)
Figure 27. APAC Vonoprazan Fumarate API Sales 2017-2022 (Kg)
Figure 28. APAC Vonoprazan Fumarate API Revenue 2017-2022 ($ Millions)
Figure 29. Europe Vonoprazan Fumarate API Sales 2017-2022 (Kg)
Figure 30. Europe Vonoprazan Fumarate API Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Vonoprazan Fumarate API Sales 2017-2022 (Kg)
Figure 32. Middle East & Africa Vonoprazan Fumarate API Revenue 2017-2022 ($ Millions)
Figure 33. Americas Vonoprazan Fumarate API Sales Market Share by Country in 2021
Figure 34. Americas Vonoprazan Fumarate API Revenue Market Share by Country in 2021
Figure 35. United States Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Vonoprazan Fumarate API Sales Market Share by Region in 2021
Figure 40. APAC Vonoprazan Fumarate API Revenue Market Share by Regions in 2021
Figure 41. China Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Vonoprazan Fumarate API Sales Market Share by Country in 2021
Figure 48. Europe Vonoprazan Fumarate API Revenue Market Share by Country in 2021
Figure 49. Germany Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Vonoprazan Fumarate API Revenue Market Share by Country in 2021
Figure 56. Egypt Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Vonoprazan Fumarate API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Vonoprazan Fumarate API in 2021
Figure 62. Manufacturing Process Analysis of Vonoprazan Fumarate API
Figure 63. Industry Chain Structure of Vonoprazan Fumarate API
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)